FDA v. Alliance for Hippocratic Medicine: - The Supreme Court could devastate nationwide access to a safe and effective medication used in over 60% of all abortions.

The Court stayed the lower court’s decision and agreed to hear the case.12 The Supreme Court will hear oral arguments in Alliance for Hippocratic Medicine v. [...] Medication abortion allows patients to access care in Mifepristone was first approved by the FDA in 2000 after regions where providers are limited, avoid the financial and an in-depth review of the evidence, and mifepristone’s logistical challenges of traveling long distances, and to have substantial record of safety and efficacy has only grown an abortion at a place of their choosing with the sup. [...] have used mifepristone abortion has been vital to bridging the gaps in care for for medication abortion and miscarriage management.15 communities facing the most obstacles to care, in particular The two-drug medication abortion regimen approved through telehealth access in states where abortion is limited by the FDA, which involves taking one mifepristone pill or severely restricted.29 If the Supr. [...] the FDA’s approval of mifepristone was unlawful, effectively On April 21, 2023, the Court granted an emergency imposing a nationwide ban on mifepristone.42 Judge application for a stay of the district court decision, opting Kacsmaryk stayed the FDA’s nearly 25-year-old approval of to maintain the status quo with respect to availability of the medication, but delayed enforcement for seven days mife. [...] Alliance for Hippocratic Medicine (AHM) are the lead appellees and are joined by three anti- abortion groups—American Association of Pro-Life Obstetricians and Gynecologists (AAPLOG), the American College of Pediatricians, and Christian Medical and Dental Associations—and their members as well as four individual doctors in challenging the FDA’s approval of mifepristone.